As per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is ‘failed dissolution specifications’.
Cipla recalls 4,800 bottles of anti-HIV tablets from US
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain